Table 1 Characteristics of the study population and biomarker levels
From: Salivary uric acid as a noninvasive biomarker of metabolic syndrome
| Â | Total (n=78) | Without Metabolic Syndrome (n=51) | With Metabolic Syndrome(n=27) | p |
|---|---|---|---|---|
Age | 43.5±1.8 | 38.0±15.5 | 53.7±10.2 | .000 |
Gender (male/female) | 27/51 | 17/34 | 10/17 | .745 |
History of periodontal disease (%) | 21.8% | 13.7% | 37.0% | .018 |
BMI* | 26.3±1.2 | 24.5±1.2 | 31.6±1.1 | .000 |
Waist Circumference (cm) | 91.5±14.3 | 84.9±10.6 | 103.9±11.9 | .000 |
Triglycerides (mg/dL)* | 97.7±1.8 | 79.4±1.5 | 147.9±2.0 | .000 |
HDL(mg/dL)* | 45.7±1.4 | 50.1±1.3 | 37.2±1.3 | .000 |
Total Cholesterol (mg/dL) | 189.1±41.1 | 176.9±34.3 | 212.1±43.5 | .000 |
Glucose (mg/dL) | 91.3±10.1 | 88.6±8.0 | 96.4±11.8 | .001 |
Systolic BP (mmHg) | 120.2±13.6 | 114.8±11.1 | 130.4±12.3 | .000 |
Diastolic BP (mmHg) | 78.5±10.3 | 74.4±7.2 | 86.1±11.1 | .000 |
Salivary Uric Acid (M) | 217.2±110.3 | 184.9±78.4 | 278.1±135.3 | .002 |
Salivary flow rate (mL/min)* | 0.46±0.72 | 0.48±0.47 | 0.43±0.53 | .468 |